InvestorsHub Logo
Followers 43
Posts 4314
Boards Moderated 0
Alias Born 09/01/2017

Re: mike00h post# 502282

Sunday, 08/07/2022 6:08:15 PM

Sunday, August 07, 2022 6:08:15 PM

Post# of 704605
The idea of using one’s own immune system to do exactly what it is supposed to do is intuitively a great approach, and was the initial takeaway from my due diligence when I first invested in nwbo over a dozen years ago.

All the treatments my mom was given in her fight against cancer were immune related in one way or another, however none employed a whole tumor lysate approach, instead targeting one or another protein or vascular element, resulting in some debilitating side effects and failure to deal with the cancer’s changes to escape the attacks.

I tried to get her treated with DCVax but between not storing the surgically removed tumor properly and oncologists sticking to more standard options and experimental treatments that they had trials they were running.

I suspect that having shown efficacy against GBM and against other cancers treated under compassionate/private access, DCVax will be successful as a broad treatment approach as the company envisions (DCVax platform.)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News